[ { "@graph" : [ { "@id" : "http://purl.org/np/RAyYJo38dTw6Ss_FhpVjz6oxfvGmQQfDWzzNidHBxaRTs", "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ], "http://www.nanopub.org/nschema#hasAssertion" : [ { "@id" : "http://purl.org/np/RAyYJo38dTw6Ss_FhpVjz6oxfvGmQQfDWzzNidHBxaRTs#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance" : [ { "@id" : "http://purl.org/np/RAyYJo38dTw6Ss_FhpVjz6oxfvGmQQfDWzzNidHBxaRTs#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo" : [ { "@id" : "http://purl.org/np/RAyYJo38dTw6Ss_FhpVjz6oxfvGmQQfDWzzNidHBxaRTs#pubInfo" } ] } ], "@id" : "http://purl.org/np/RAyYJo38dTw6Ss_FhpVjz6oxfvGmQQfDWzzNidHBxaRTs#Head" }, { "@graph" : [ { "@id" : "http://identifiers.org/drugbank/DB01267", "@type" : [ "https://w3id.org/biolink/vocab/Drug" ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "Paliperidone" } ], "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Drug" } ] }, { "@id" : "http://purl.obolibrary.org/obo/HP_0000737", "@type" : [ "https://w3id.org/biolink/vocab/Disease" ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "Irritability" } ], "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Disease" } ] }, { "@id" : "http://purl.org/np/RAyYJo38dTw6Ss_FhpVjz6oxfvGmQQfDWzzNidHBxaRTs#association", "@type" : [ "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation" ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ { "@id" : "http://purl.obolibrary.org/obo/HP_0000737" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ { "@id" : "https://w3id.org/biolink/vocab/treats" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ { "@id" : "http://identifiers.org/drugbank/DB01267" } ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "Stigler et al. [10] evaluated the effectiveness and tolerability of paliperidone for irritability in ASD. In this 8-week, prospective, open-label study, 21 (84%) of 25 subjects with ASD (mean age, 15.3 years) were considered responders to paliperidone (mean dosage, 7.1 mg/day), based on Clinical Global Impression (CGI)- Improvement and Aberrant Behaviour Checklist-Irritability sub- scale.v" } ], "https://w3id.org/biolink/vocab/aggregator_knowledge_source" : [ { "@id" : "https://w3id.org/biolink/infores/knowledge-collaboratory" } ], "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation" } ], "https://w3id.org/biolink/vocab/has_population_context" : [ { "@id" : "http://purl.org/np/RAyYJo38dTw6Ss_FhpVjz6oxfvGmQQfDWzzNidHBxaRTs#context" } ], "https://w3id.org/biolink/vocab/publications" : [ { "@id" : "http://www.ncbi.nlm.nih.gov/pubmed/31096228" } ], "https://w3id.org/biolink/vocab/relation" : [ { "@id" : "http://purl.obolibrary.org/obo/NCIT_C94303" } ] }, { "@id" : "http://purl.org/np/RAyYJo38dTw6Ss_FhpVjz6oxfvGmQQfDWzzNidHBxaRTs#context", "@type" : [ "https://w3id.org/biolink/vocab/Cohort" ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "Children and adolescents (mean age 15.3 years)" } ], "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Cohort" } ], "https://w3id.org/biolink/vocab/has_phenotype" : [ { "@id" : "http://purl.obolibrary.org/obo/MONDO_0005258" } ] } ], "@id" : "http://purl.org/np/RAyYJo38dTw6Ss_FhpVjz6oxfvGmQQfDWzzNidHBxaRTs#assertion" }, { "@graph" : [ { "@id" : "http://purl.org/np/RAyYJo38dTw6Ss_FhpVjz6oxfvGmQQfDWzzNidHBxaRTs#assertion", "http://www.w3.org/ns/prov#wasAttributedTo" : [ { "@id" : "https://orcid.org/0000-0002-7641-6446" } ] } ], "@id" : "http://purl.org/np/RAyYJo38dTw6Ss_FhpVjz6oxfvGmQQfDWzzNidHBxaRTs#provenance" }, { "@graph" : [ { "@id" : "http://purl.org/np/RAyYJo38dTw6Ss_FhpVjz6oxfvGmQQfDWzzNidHBxaRTs", "http://www.w3.org/ns/prov#generatedAtTime" : [ { "@type" : "http://www.w3.org/2001/XMLSchema#dateTime", "@value" : "2022-09-16T11:50:42.254483" } ], "http://www.w3.org/ns/prov#wasAttributedTo" : [ { "@id" : "https://orcid.org/0000-0002-1501-1082" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ { "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY" } ] }, { "@id" : "http://purl.org/np/RAyYJo38dTw6Ss_FhpVjz6oxfvGmQQfDWzzNidHBxaRTs#sig", "http://purl.org/nanopub/x/hasAlgorithm" : [ { "@value" : "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey" : [ { "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature" : [ { "@value" : "NeH/8kC8VK3DP1/tbL1yIoGGwguuxVycaDYHS/YKAT8vvDD8/+NQBUt+nn0gOEvKZAtEJWG7dx5qf3KUY7GecQ/CYzgiGblTO7a2NDJELGVcI0k13Yb9uAPFcDNvQNIev0YqKJm5J3bUepHbAsFE8iCwoJOwEjVWB9cbIH+gYpk=" } ], "http://purl.org/nanopub/x/hasSignatureTarget" : [ { "@id" : "http://purl.org/np/RAyYJo38dTw6Ss_FhpVjz6oxfvGmQQfDWzzNidHBxaRTs" } ] }, { "@id" : "https://w3id.org/biolink/vocab/", "http://purl.org/pav/version" : [ { "@value" : "2.3.0" } ] } ], "@id" : "http://purl.org/np/RAyYJo38dTw6Ss_FhpVjz6oxfvGmQQfDWzzNidHBxaRTs#pubInfo" } ]